Cepheid plans follow-on offering of 10 million shares via UBS

By Ronda Fears

Memphis, Feb. 24 - Cepheid, Inc. announced Friday plans to sell 10 million shares of common stock off the shelf via bookrunner UBS Investment Bank.

Co-managers are William Blair & Co. and Robert W. Baird & Co.

Sunnyvale, Calif.-based Cepheid is a molecular diagnostics company that develops, manufactures and markets fully integrated systems for genetic analysis in the clinical, industrial and biothreat markets.

Cepheid shares (Nasdaq: CPHD) gained 28 cents, or 3.08%, to close Friday at $9.36.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.